Search
Deutivacaftor
go.drugbank.com/drugs/DB15141ApprovedInvestigationalDeutivacaftor is a small molecule cystic fibrosis transmembrane conductance regulator (CFTR) potentiator. It is used alongside CFTR correctors to increase the quantity and function of CFTR at the cell surface in patients with cystic fibr...
Synonyms: D9-IvacaftorCategories: Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP2C9 InhibitorsPepinemab
go.drugbank.com/drugs/DB15155InvestigationalPepinemab is under investigation in clinical trial NCT03769155 (VX15/2503 With or Without Ipilimumab and/or Nivolumab in Patients With Resectable Stage IIIB-D Melanoma).
Dextromethadone
go.drugbank.com/drugs/DB15198InvestigationalDextromethadone is under investigation in clinical trial NCT00588640 (Study of D-Methadone in Patients With Chronic Pain).
Synonyms: D-methadoneD-fluoromethyltyrosine F-18
go.drugbank.com/drugs/DB15296InvestigationalD-fluoromethyltyrosine F-18 is under investigation in clinical trial NCT01089998 (PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety
Pradefovir
go.drugbank.com/drugs/DB15550InvestigationalPradefovir is a prodrug of adefovir.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesLeptazoline D
go.drugbank.com/drugs/DB15554ExperimentalLeptazoline D is a polar oxazoline from the Cyanobacterium Leptolyngbya sp. Also see [Leptazoline A], [Leptazoline B], and [Leptazoline C].
Synonyms: Leptazoline DDesfesoterodine
go.drugbank.com/drugs/DB15578InvestigationalDesfesoterodine is a metabolite of tolterodine.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2D6 SubstratesCryptotanshinone
go.drugbank.com/drugs/DB15579ExperimentalCategories: Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP2C9 InhibitorsPrevitamin D(3)
go.drugbank.com/drugs/DB15614InvestigationalCategories: Vitamin D and AnaloguesSynonyms: Previtamin D, Previtamin D3Brensocatib
go.drugbank.com/drugs/DB15638ApprovedNon-cystic fibrosis bronchiectasis (NCFB) is a chronic lung disease characterized by airway widening, mucus accumulation, and neutrophilic inflammation. Brensocatib is a first-in-class dipeptidyl peptidase 1 (DPP1) inhibitor that inhibit...
Synonyms: (S)-N-((S)-1-Cyano-2-(4-(3-methyl-2-oxo-2,3-dihydrobenzo-(d)oxazol-5-yl)phenyl)ethyl)-1,4-oxazepane-2-carboxamideCategories: P-glycoprotein substrates, Cytochrome P-450 CYP3A Inducers